10X Genomics (TXG)
NASDAQ:TXG
Want to see TXG full AI Analyst Report?
10x Genomics (TXG) Ownership Overview
2.00% Insiders
25.89% Mutual Funds
33.22% Other Institutional Investors
26.72% ETFs
12.18% Public Companies and
Individual Investors
The ownership structure of 10x Genomics (TXG) stock is a mix of institutional, retail, and individual investors. Approximately 85.82% of the company’s stock is owned by Institutional Investors, 2.00% is owned by Insiders, and 12.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 27, 2026 | xxxxxxxxxxxxx | $444197 | |
May 27, 2026 | xxxxxxxxxxxxx | $283382 | |
May 27, 2026 | xxxxxxxxxxxxx | $368995 | |
Feb 25, 2026 | xxxxxxxxxxxxx | $178866 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $1337490 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $248758640 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $745194 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,717,317 | Institution | 10.03% | 363,705,520 | |
| 10,435,748 | Institution | 8.93% | 323,925,618 | |
| 10,216,402 | Institution | 8.74% | 317,117,118 | |
| 9,288,224 | Institution | 7.95% | 288,306,473 | |
| 5,125,039 | Institution | 4.38% | 159,081,211 | |
| 3,567,372 | Institution | 3.05% | 110,731,227 | |
| 1,710,805 | Institution | 1.46% | 53,103,387 | |
| 1,452,300 | Institution | 1.24% | 45,079,392 | |
| 1,423,301 | Insider | 1.22% | 44,179,263 | |
| 1,209,815 | Institution | 1.04% | 37,552,658 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,288,224 | Institution | 7.95% | 288,306,473 | |
| 3,567,372 | Institution | 3.05% | 110,731,227 | |
| 1,710,805 | Institution | 1.46% | 53,103,387 | |
| 1,452,300 | Institution | 1.24% | 45,079,392 | |
| 1,209,815 | Institution | 1.04% | 37,552,658 | |
| 1,197,010 | Institution | 1.02% | 37,155,190 | |
| 1,159,246 | Institution | 0.99% | 35,982,996 | |
| 1,153,640 | Institution | 0.99% | 35,808,986 | |
| 1,000,000 | Institution | 0.86% | 31,040,000 | |
| 865,305 | Institution | 0.74% | 26,859,067 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,864,204 | Institution | 5.87% | 213,064,892 | |
| 3,759,177 | Institution | 3.22% | 82,889,853 | |
| 2,891,676 | Institution | 2.47% | 89,757,623 | |
| 2,708,091 | Institution | 2.32% | 59,713,407 | |
| 2,631,534 | Institution | 2.25% | 81,682,815 | |
| 1,520,902 | Institution | 1.30% | 33,535,889 | |
| 1,326,512 | Institution | 1.13% | 29,249,590 | |
| 824,717 | Institution | 0.71% | 25,599,216 | |
| 718,012 | Institution | 0.61% | 22,287,092 | |
| 568,786 | Institution | 0.49% | 19,054,331 |
FAQ
Who Owns 10X Genomics (TXG)?
According to the latest TipRanks data, approximately 33.22% of the company's stock is held by institutional investors, 2.00% is held by insiders, and 12.18% is held by retail investors.
What percentage of 10X Genomics (TXG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.22% of 10X Genomics (TXG) stock is held by institutional investors.
What percentage of 10X Genomics (TXG) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.18% of 10X Genomics (TXG) stock is held by retail investors.
Who owns the most shares of 10X Genomics (TXG)?
Cathie Wood owns the most shares of 10X Genomics (TXG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.